UPDATE: Evercore Partners Takeaways from CME Group Management Meeting; Raises PT
According to a research report published today by Evercore Partners, a recent meeting with CME Group's (NASDAQ: CME) management showed growth opportunities in a number of areas.
“Greatest in near- to intermediate-term remains expansion of core platform globally, with a meaningful focus on Asia. Colocation, index services, and OTC clearing fall into 2nd tier of the opportunity set,” Evercore Partners said in the report.
Evercore Partners maintains its Equal-Weight rating, and increases CME Group's PT from $250 to $285. CME Group is currently trading at $289.56.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.